Global Insights: Shiyue Daotian Group Among 3 Prominent Penny Stocks

Amidst a backdrop of fluctuating global markets, where major indices like the Nasdaq Composite and S&P 500 have recently faced declines, investors are increasingly exploring alternative investment avenues. Penny stocks, a term that may seem outdated but remains pertinent, continue to attract attention for their potential to uncover growth opportunities in smaller or newer companies. When these stocks are supported by strong financial health, they can offer intriguing prospects with less risk than traditionally perceived.

We're going to check out a few of the best picks from our screener tool.

Shiyue Daotian Group (SEHK:9676)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Shiyue Daotian Group Co., Ltd. is a company that manufactures and sells pantry staple food in the People's Republic of China, with a market cap of HK$4.22 billion.

Operations: The company's revenue is primarily derived from Rice Products at CN¥4.76 billion, followed by Corn Products at CN¥740.35 million, Dried Food and Other Products at CN¥675.87 million, and Whole Grain, Bean and Other Products at CN¥638.68 million.

Market Cap: HK$4.22B

Shiyue Daotian Group, with a market cap of HK$4.22 billion, primarily generates revenue from rice products totaling CN¥4.76 billion. Despite a low return on equity of 11.2%, its earnings have shown substantial growth, increasing by 109.6% over the past year and outpacing the food industry average significantly. The company has managed its liabilities well, with short-term assets exceeding both short and long-term liabilities, although operating cash flow remains negative impacting debt coverage. Recently, it approved a dividend distribution despite concerns about sustainability due to insufficient free cash flows covering it effectively.

• Jump into the full analysis health report here for a deeper understanding of Shiyue Daotian Group.
• Gain insights into Shiyue Daotian Group's outlook and expected performance with our report on the company's earnings estimates.

ZJBC Information Technology (SZSE:000889)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: ZJBC Information Technology Co., Ltd, with a market cap of CN¥2.94 billion, provides information intelligent transmission services in China through its subsidiaries.

Operations: The company generates its revenue primarily from its operations in China, amounting to CN¥1.59 billion.

Market Cap: CN¥2.94B

ZJBC Information Technology Co., Ltd, with a market cap of CN¥2.94 billion, reported annual revenue of CN¥1.59 billion for 2025, reflecting growth from the previous year despite a net loss of CN¥26.47 million. The company has reduced its losses over the past five years at a significant rate and maintains a satisfactory net debt to equity ratio of 4.8%. However, it faces challenges such as high share price volatility and insufficient short-term assets to cover liabilities fully. Positively, ZJBC has an experienced board and sufficient cash runway for more than three years if current trends continue.

• Get an in-depth perspective on ZJBC Information Technology's performance by reading our balance sheet health report here.
• Understand ZJBC Information Technology's track record by examining our performance history report.

Jiangsu Baoli International Investment (SZSE:300135)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Jiangsu Baoli International Investment Co., Ltd. operates in the investment sector and has a market cap of CN¥2.80 billion.

Operations: The company generates revenue of CN¥1.49 billion from its operations in China.

Market Cap: CN¥2.8B

Jiangsu Baoli International Investment Co., Ltd. has a market cap of CN¥2.80 billion and reported annual revenue of CN¥1.37 billion for 2025, experiencing a decline from the previous year and resulting in a net loss of CN¥98.47 million. Despite this, the company shows financial resilience with short-term assets exceeding both short- and long-term liabilities, alongside an acceptable net debt to equity ratio of 26.5%. Recent private placement approval could bolster its cash runway beyond the current nine months forecasted based on free cash flow estimates, while management remains experienced with an average tenure exceeding four years.

• Click here to discover the nuances of Jiangsu Baoli International Investment with our detailed analytical financial health report.
• Examine Jiangsu Baoli International Investment's past performance report to understand how it has performed in prior years.

Taking Advantage

• Access the full spectrum of 3,646 Global Penny Stocks by clicking on this link.
• Seeking Other Investments? Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com